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Specialists’ adherence to guidelines  
on tympanostomy tube insertion
Tympanostomy tube (TT) insertion is a well-estab-
lished and frequent treatment option for children suf-
fering from otitis media (OM). OM comprises acute OM 
(AOM), OM with effusion (OME) and chronic OME 
with effusion (COME) and is estimated to affect at least 
60% of Danish pre-school aged children [1]. A recent 
Danish study found an average annual number of 
36,196 TT insertions in approximately 19,000 children 
aged 0-15 years between 1997 and 2011 [2]. The same 
study predicted that at least 24% of Danish children 
would undergo TT insertion before the age of three 
years. Private practicing ear, nose & throat (ENT) spe-
cialists perform the vast majority of these TT insertions, 
whereas a minor part is performed at hospitals. 
According to another Danish study, socio-economic 
factors such as reduced smoking, prolonged maternity 
leave, higher welfare and introduction of childhood 
vaccines have improved in the past 30 years [1]. As 
these factors are risk factors for OM, a reduction in OM 
incidence would be expected. Contrarily, more children 
spend more time in day-care centres today than 30 
years ago, which may balance-out the influence of the 
decrease in OM risk factors. The extent to which these 
factors affect the incidence of OM and consequently the 
TT insertion frequency in Danish children remains un-
clear [1]. Even so, the total number of TT insertions 
performed nationally has declined slightly and gradu-
ally since 2010 according to data from Danish Regions. 
This may, in part, be explained by the introduction of 
the pneumococcal conjugate 13-valent vaccine 
(PCV13) in 2010 [3]. Despite considerable regional dif-
ferences in the number of procedures performed, Den-
mark still has the highest registered rate of TT insertion 
per habitant in the world [2, 4].
Owing to a Danish Consensus Conference in 1987, 
the first national approach to a standardised treatment 
strategy for children with OME was prepared. How-
ever, this guideline did not include children with 
RAOM, and general uncertainty remained regarding 
correct identification of patients best suited for surgical 
candidacy [5]. In 2015, the Danish Health Authority 
published a new national clinical guideline (NCG) on 
TT insertion in children aged 0-5 years with COME 
and/or RAOM [6]. The recommendations for TT inser-
tion are listed in Table 1.
 The present study aimed to explore if electronic 
parent-reported outcome (ePRO) data may be used to 
evaluate private Danish ENT specialists’ adherence to 
the 2015 NCG on children with OM based on symptom 
duration and number of AOM episodes prior to TT in-
sertion.  
METHODS
Data were extracted from the Danish ENT Specialists 
ABSTRACT
INTRODUCTION: Tympanostomy tube insertion is very 
frequent in Denmark. Using electronic patient-reported 
outcome (ePRO) data, we investigated Danish ear, nose & 
throat (ENT) specialists’ adherence to the 2015 national 
clinical guideline (NCG) on first-time tympanostomy tube 
(TT) insertion in children aged 0-5 years with otitis media 
(OM). 
METHODS: Data on children aged 0-5 years with OM 
undergoing first-time TT insertion were extracted from the 
Danish ENT Specialists Organisation (DØNHO) database. Pre-
operative questionnaires were used to obtain information on 
symptom duration, and the number of acute OM (AOM) 
episodes was analysed. The following criteria were 
established to define NCG adherence: 1) A symptom duration 
of three months or longer, 2) three or more AOM episodes 
within six months and 3) four or more AOM episodes within 
12 months. These criteria are in accordance with the NCG 
definition of chronic OM with effusion (COME) and recurrent 
AOM (RAOM). 
RESULTS: A total of 1,495 children were included in the 
study. In total, 91.0% of the parents reported a symptom 
duration of three months or more and/or RAOM within 6-12 
months prior to TT insertion in accordance with the 
adherence criteria; 4.6% reported a symptom duration of 
less than three months with few or no episodes of AOM and 
did not meet the recommended TT insertion criteria. Finally, 
4.4% of the parents were undecided with respect to 
symptom duration, number of AOM episodes or both at 6-12 
months prior to TT insertion. 
CONCLUSIONS: Using solely ePRO data, we found that 
Danish practicing ENT specialists adhere to the 2015 NCG in 
regard to OM symptom duration and RAOM.
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Organisation (DØNHO) database, which was estab-
lished as a pilot project in 2017 by a group of 26 Danish 
private ENT specialists. Data were collected using the 
Danish National Tympanostomy Tube Insertion Ques-
tionnaires (DANTIQ). The database currently contains 
the first pre- and post-operative ePRO data on more 
than 3,500 children below 12 years of age in whom TT 
insertion was performed under general anaesthesia in 
private ENT practice settings between March 2017 and 
August 2018. The database is currently growing since 
patient registration and data collection are on-going.  
If needed, the database can be expanded prospectively 
to include all 160 Danish private ENT specialists. 
The parent or caregiver of every child gave consent 
to participate at the pre-operative consultation with the 
ENT specialist. The clinic staff registered patients in the 
database. In- and exclusion criteria are shown in Table 
2. Data were encrypted and stored anonymously in the 
database. A link to the pre-operative questionnaire was 
emailed to the parents two days prior to surgery en-
quiring about the number of AOM episodes within the 
year preceding surgery; parents were also asked to tick 
off a list of ear-related symptoms and state the duration 
of these symptoms. Post-operative follow-up question-
naires were sent one month after TT insertion and 
thereafter planned at three-month intervals for a total 
of two years of follow up [7]. 
To match the patient population described in the 
NCG and thus evaluate guideline adherence, we ana-
lysed the pre-operative ePRO data of children aged 0-5 
years offered first-time TT insertion and whose parents 
had completed the pre-operative questionnaire. We es-
tablished three criteria according to the definitions of 
COME and RAOM in the NCG to define NCG adher-
ence: 1) Symptom duration of three months or longer, 
2) three or more episodes of AOM within six months or 
3) four or more episodes of AOM within 12 months.
The DANTIQ were developed by a group of Danish 
ENT specialists and have subsequently been validated 
in a separate study [8].  
The Bio-statistical Advisory Service at the University 
Hospital in Aarhus, Denmark, performed all statistical 
analyses. Confidence intervals were calculated for all 
proportions.
The study and the registration database were ap-
proved by the Danish Data Protection Agency (no. 
2016-42-3152). Ethical approval was not required  
under Danish Law. 
Trial registration: not relevant.
RESULTS
A total of 3,553 children < 12 years were registered 
during the observation period. In compliance with the 
study’s inclusion criteria, 1,495 children aged 0-5 years 
were included. Their median age was 16 months 
(range: 4-71 months), 56.7% (n = 848) were boys and 
43.3% (n = 647) were girls. An exact pre-operative re-
sponse rate could not be calculated as information re-
garding prior TT insertion had not been obtained at the 
time of registration. However, based on analysis on 
treatment effects in the same 3,553 children < 12 years 
presented elsewhere, a response rate of 75.3% regard-
ing pre-operative questionnaires was found [6]. 
Results regarding symptom duration and number of 
AOM episodes up to one year prior to TT insertion are 
presented in Table 3. The group of children not meet-
ing the NCG recommendation criteria on TT insertion 
was considered too small to be included in a compara-
tive sub-group analysis. 
TABLE 1
Summary of the Danish 2015 national clinical guideline recommendation on tympanostomy 
tube insertion in children aged 0-5 years with otitis media.
Recommendation Strength
Overall  
evidence quality
Surgical management of COME
Consider offering TT to children with bilateral COME and hearing prob-
lems with or without concurrent speech problems
↑ +
Pending careful consideration, TT insertion should be offered only to 
children with COME and behavioural problems, vestibular problems or 
lowered quality of life if the child has normal hearing, as the effect is 
uncertain 
↓ +
Pending careful consideration, TT insertion should be offered only to 
children with COME and no other symptoms since there is no evidence 
of a beneficial effect
↓ +
Surgical management of RAOM
Consider TT insertion in children with RAOM with or without middle ear 
effusion between AOM episodes 
↑ ++
AOM = acute otitis media; COME = chronic otitis media with effusion; RAOM = recurrent acute otitis media; 
TT = tympanostomy tube.
↑: weak recommendation for treatment. 
↓:  weak recommendation against treatment. 
+: low-quality level of evidence.
++: very low-quality level of evidence [5].
Tympanostomy tube in-
serted in eardrum. 
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DISCUSSION
Our main result shows good ENT specialist adherence 
to NCG recommendations with respect to symptom du-
ration and number of AOM episodes up to one year 
prior to TT insertion based on ePRO data. 
The literature does not report agreement on a min-
imally acceptable response rate [9]. However, a pre- 
operative response rate of 75.3% introduces a risk of 
non-response bias. Even so, we believe that our rela-
tively large study sample is sufficiently representative, 
why the negative effects of non-response bias are di-
minished. 
ePRO data have been acknowledged as a potential 
tool for inclusion of the patient’s experience into the 
clinical decision-making process in the treatment of 
cancer patients [10]. ePRO data have also been used as 
a tool for evaluating short-term treatment effect follow-
ing TT insertion in children below 12 years of age [7]. 
In the present study, ePRO data provided real-time and 
un-biased answers by caregivers to children 0-5 years 
of age who were offered TT insertion. In this group of 
children who themselves cannot provide information, 
caregiver response is particularly useful. In addition, 
ePRO data collection is fast, easily executed, cost-effec-
tive and time-efficient for all participating parties [7]. 
Although patient inclusion was preceded by an ENT 
specialist’s assessment and thus conditional to having 
TT insertion performed, clinical observations and ex-
aminations such as hearing-threshold measurements 
and mobility assessments of the tympanic membrane 
were not registered in the database. This is important 
when interpreting the results. 
The Danish NCG recommends the use of TT inser-
tion in children with OME when effusion persists for 
three months or longer (COME) and when a concurrent 
hearing loss is documented [6]. We found that 91.0% 
of the parents reported a symptom duration of three 
months or longer prior to TT insertion, which is in ac-
cordance with the NCG definition of COME. As paren-
tal observation has been found to correlate well with 
Danish private ENT specialists’ estimation of symptom 
duration [11], it seems reasonable to conclude from 
our findings that physicians adhere well to the NCG 
recommendation in regard to symptom duration.
Data on physician-tested hearing loss were not 
regis tered in the present study, and data on hearing 
loss rely solely on the parents’ reports on pre-operative 
“sense of hearing loss” as is the nature of ePRO data. 
Parents’ reports on hearing loss have been shown to be 
of debatable value [12, 13]. In Denmark, it is the inten-
tion that hearing-threshold measurements form an in-
tegrated part of ENT specialists’ assessment pro-
gramme in children with OM prior to medical or 
surgical treatment. In the present study, knowledge of 
TABLE 2
DØNHO database Study population
Criteria of participation
Inclusion Children aged 0-11 yrs undergoing TT insertion in GA Children aged 0-5 yrs undergoing first-time TT insertion in GA
Exclusion Children aged ≥ 12 yrs
Parents without an e-mail address
Parent with insufficient language capabilities
Parents who did not wish to participate
Parents with insufficient cognitive capabilities
Parents with illiteracy
Children aged ≥ 6 yrs
Parents without an e-mail address
Parents with insufficient language capabilities
Parents who did not wish to participate
Parents with insufficient cognitive capabilities
Parents with illiteracy
Questionnaires
Preoperative 2 days before surgery 2 days before surgery
Post-operative After 1 mo. –
After 3, 6, 9, 12, 15, 18, 21, 24 mo.s
DØNHO = Danish ear, nose & throat specialist organisation; GA = general anaesthesia; TT = tympanostomy tube.
Criteria for inclusion 
and exclusion of 
children in the DØNHO 
database and the pre-
sent study on ear, nose 
& throat specialists’ 
adherence to the Dan-
ish 2015 national  
clinical guideline on 
tympanostomy tube in-
sertion.
TABLE 3
Private ear, nose & throat specialists’ adherence to the Danish 2015 national clinical guideline 
on tympanostomy tube insertion in children aged 0-5 years with otitis media assessed by 
electronic patient-reported outcome data on symptom duration and number of acute otitis 
media episodes prior to surgery (N = 1,495). 
n % (95% CI)
Adherence to NCG recommendations
Symptom duration ≥ 3 mo.s and/or concurrent RAOM 1,318 88.2 (86.4-89.8)
Symptom duration ≥ 3 mo.s and unknown number of AOM episodes     27   1.8 (1.2-2.6)
RAOM and symptom duration < 3 mo.s     12   0.8 (0.4-1.4)
RAOM and unknown symptom duration       3   0.2 (0.04-0.6)
Deviation from NCG recommendations
Symptom duration < 3 mo.s and no concurrent RAOM     69   4.6 (3.6-4.8) 
Symptom duration < 3 mo.s and unknown number of AOM episodes      4    0.3 (0.07-0.7)
Unknown symptom duration and no concurrent RAOM    57   3.8 (2.9-4.9)
Unknown symptom duration and number of AOM episodes      5   0.3 (0.1-0.8)
AOM = acute otitis media; CI = confidence interval; NCG = national clinical guideline; RAOM = recurrent AOM.
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potential hearing loss prior to TT insertion would 
therefore have been beneficial. However, other ear- 
related problems aside from hearing loss seem impor-
tant as shown in a study on the short-term effect of TT 
insertion in children with OM, where significant relief 
in symptoms such as interrupted sleep and earache was 
found [7]. This implies that TT insertion has an effect 
on other symptoms associated with COME and RAOM 
than hearing loss. Based on this, we disregarded data 
on parent-reported hearing loss in the present study. 
The Danish NCG is almost identical to international 
clinical practice guidelines in regard to recommenda-
tions for TT insertion in children with COME [6, 14, 
15]. The clinical practice guideline of the American 
Academy of Otolaryngology – Head and Neck Surgery 
Foundation (AAO-HNSF) and the guideline on surgical 
management of children with OME of the UK National 
Institute of Clinical Excellence (NICE) both recommend 
TT insertion in children with bilateral COME and con-
current, documented hearing loss, and/or other symp-
toms likely caused by or attributable to COME; e.g. 
physical, cognitive or behavioural issues leading to 
speech, language or learning difficulties [14, 15]. 
Direct evidence on TT insertion in children with RAOM 
is limited, and international guideline recommenda-
tions vary slightly. However, Danish and American 
guidelines both favour TT insertion in children with 
middle-ear effusion between AOM episodes [6, 14].
In 2010, Johansen et al [11] investigated private 
ENT specialists’ adherence to the Danish guideline rec-
ommendation on TT insertion from 1987. A group of 
426 children aged 0-6 years who underwent first-time 
TT insertion were included. Of these, 80% were ob-
served by a general practitioner or an ENT specialist for 
three months or longer before surgery, which was in 
agreement with the current guideline recommenda-
tion. 
In 2017, Hughes et al [16] evaluated the appropri-
ateness of TT insertion and American ENT specialists’ 
guideline adherence to the AAO-HNSF clinical practice 
guideline on TT insertion in a group of 120 children 
aged less than nine years who underwent TT insertion. 
The study reported 75% adherence to the AAO-HNSF 
guideline, but in 5% TT insertion substantially deviated 
from the guideline.
In 2015, Daniel et al [17] examined British ENT 
specialists’ adherence to the NICE guidelines on sur-
gical management of COME by retrospectively studying 
the records of 319 children aged less than 12 years with 
TT insertion. The study reported only 32% complete 
adherence to the NICE guideline’s so-called “core crit-
eria” regarding COME-attributed hearing loss (two au-
diograms obtained at a three-month interval with a 
hearing level in the better ear at 25-30 dB normal hear-
ing level or poorer). However, accordance with NICE 
guidelines rose to 87% if exceptional cases were in-
cluded, e.g. cases with developmental, social or educa-
tional status issues caused by the presence of COME. 
The high number of children having TTs due to excep-
tional circumstances led to the conclusion that clini-
cians were adapting the treatment to the individual 
child’s needs. It also implied that these cases were more 
the norm than the exception. 
There seems to be a well-established international 
consensus that COME-attributed hearing loss is the 
main reason for TT insertion in children [6, 14, 15, 18]. 
However, in everyday clinical practice, ENT specialists 
and parents may base their treatment decision on the 
children’s general well-being as well as on symptoms 
such as interrupted sleep and earache when offering TT 
insertion in children with OM [19, 20].
Our study is based on ePRO data and is susceptible 
to selection bias on the part of the parents, who may 
prefer TT insertion. The study design did not include a 
control group, and the absence of data on potential 
hearing loss is a limitation. To strengthen the validity 
of the study, hearing-threshold measurements and mo-
bility assessment of the tympanic membrane are 
needed. However, we believe that our data show a sur-
gical treatment trend among Danish private ENT spe-
cialists that seems to adhere extensively to the Danish 
2015 NCG on TT insertion in children aged 0-5 years 
with OM. 
Unfortunately, recommendations on TT insertion 
are based on studies that are neither controlled nor 
randomised [6]. Available evidence is sparse, and 
guideline adherence alone cannot guarantee correct 
use of TT insertion. Until more substantial evidence is 
presented, guideline interpretation must be done care-
fully and additional criteria may evolve. TT insertion 
should be preceded by a thorough parent-reported 
symptom history as well as a standardised ENT special-
ist assessment. Monitoring of this by, e.g., use of ePRO 
data, is important.
CONCLUSIONS
With respect to parent-reported symptom duration 
and/or RAOM alone without reference to hearing 
threshold measurements pre-operatively, private ENT 
specialists seem to adhere well to the 2015 NCG on TT 
insertion in children aged 0-5 years with OM. 
Optimal evaluation of guideline adherence would 
require a pre-operative hearing test; however, as this 
report relied solely on ePRO data, analysis of such data 
was beyond the scope of the study. 
Finally, ePRO data are a promising tool for monitor-
ing adherence to guidelines among private ENT spe-
cialists in Denmark.
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